Cell surface receptors, virus entry and tropism of primate lentiviruses

Journal of General Virology

Volumn 83, Issue 8, 2002, Pages 1809-1829

  Clapham, Paul R ^a   McKnight, Áine ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 4 [(4 BROMOPHENYL)(ETHOXYIMINO)METHYL] 1' [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4' METHYL 1,4' BIPIPERIDINE; ANTIVIRUS AGENT; CD4 ANTIGEN; CELL SURFACE RECEPTOR; CURDLAN; DEXTRAN SULFATE; GLYCOPROTEIN GP 120; HEPARIN; INTERLEUKIN 16; MEMBRANE RECEPTOR; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; SCH 331125; SPIKE GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

CELL ADHESION; CELL GROWTH; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; DRUG SYNTHESIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS CORE; VIRUS PARTICLE; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; PRIMATES; RNA VIRUSES;

EID: 0036329849     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-8-1809     Document Type: Review

References (210)

1. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation
2. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
3. A new SIV co-receptor, STRL33
4. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression
5. Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor
6. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
7. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection
8. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
9. Fighting HIV-1 with IL-16
10. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication
11. Identification of two distinct subsets of long-term non-progressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis
12. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses
13. Antigenically distinct conformations of CXCR4
14. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32
15. A new classification for HIV-1
16. + T cell decline
17. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
18. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses
19. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection
20. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
21. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein
22. Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consenquences
23. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection
24. Core structure of gp41 from the HIV envelope glycoprotein
25. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
26. mac
27. Natural infection of a homozygous Δ24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus
28. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
29. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
30. The orphan seven-transmembrane receptor APJ supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
31. + T cells by macrophage-tropic HIV envelope
32. Immunodeficiency viruses. Spoilt for choice of co-receptors
33. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells
34. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus
35. HIV entry into cells by CD4-independent mechanisms
36. + T cells
37. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: Lack of association with mutations other than CCR5-Δ32
38. + T cells
39. lek
40. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population
41. Signaling and functional properties of interleukin-16
42. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120
43. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
44. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers
45. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
46. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Francisco City Cohort, ALIVE Study
47. Co-expression of CXCR4/fusin and galacto-sylceramide in the human intestinal epithelial cell line HT-29
48. Identification of a major co-receptor for primary isolates of HIV-1
49. Expression cloning of new receptors used by simian and human immunodeficiency viruses
50. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
51. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
52. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
53. + cells is mediated by the chemokine receptor CC-CKR-5
54. Virus membrane fusion proteins: Biological machines that undergo a metamorphosis
55. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
56. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
57. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
58. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor
59. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
60. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
61. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
62. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection
63. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis
64. The role of mononuclear phagocytes in HTLV-III/LAV infection
65. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
66. Human immunodeficiency virus neurotropism: An analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia
67. Global survey of genetic variation in CCR5, RANTES, and MIP-1α: Impact on the epidemiology of the HIV-1 pandemic
68. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity
69. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity
70. Immature dendritic cells selectively replicate macrophage-tropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells
71. Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
72. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells
73. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide
74. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
75. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding
76. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
77. + cells from virus binding
78. CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons
79. Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1
80. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins
81. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
82. Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
83. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
84. Analysis of the contact sites on the CD4 molecule with class II MHC molecule: Co-ligand versus co-receptor function
85. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
86. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro
87. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation
88. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro
89. Zafirlukast: The first leukotriene-receptor antagonist approved for the treatment of asthma
90. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
91. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
92. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
93. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
94. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy
95. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5
96. Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition
97. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1
98. Influence of the CCR2-V641 polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4
99. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
100. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor
101. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
102. Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation
103. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
104. CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus
105. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
106. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro
107. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
108. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study
109. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
110. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4
111. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
112. Protective effect of CCR2-641 and not of CCR5-Δ32 and SDF1-3′ A in pediatric HIV-1 infection
113. CXCR4 polymorphisms and HIV-1 pathogenesis
114. Genetic acceleration of AIDS progression by a promoter variant of CCR5
115. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice
116. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor
117. Chemokine control of HIV-1 infection
118. HIV-1 entry inhibitors: Evading the issue
119. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32
120. + cells
121. Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding
122. Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4
123. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
124. Dissociation of gp120 from HIV-1 virions induced by soluble CD4
125. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
126. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
127. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
128. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
129. Energetics of the HIV gp120-CD4 binding reaction
130. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype
131. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
132. + T cells are infected in human immunodeficiency virus type 1-infected individuals
133. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells
134. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells
135. Crystal structure of rhodopsin: A G protein-coupled receptor
136. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity
137. Subpopulations of peripheral blood dendritic cells show differential susceptibility to infection with a lymphotropic strain of HIV-1
138. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus virus type 1 infection and release infectious virus
139. CCR5 genotype and resistance to vertical transmission of HIV-1
140. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
141. Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry
142. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region
143. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans
144. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
145. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity
146. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
147. CD4 and signal transduction
148. HIV-1 selection by epidermal dendritic cells during transmission across human skin
149. CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry
150. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
151. Structural biology of chemokine receptors
152. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
153. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
154. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking non-syncytium-inducing HIV-1 in vitro
155. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues
156. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: Functional complementation of specific defects in gp120 and gp41
157. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains
158. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule
159. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection
160. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
161. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
162. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
163. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial
164. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus
165. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
166. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
167. Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS
168. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia
169. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: Role of the V1/V2 domains
170. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses
171. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
172. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
173. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
174. Membrane fusion by influenza hemagglutinin
175. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter San Francisco City Cohort (SFCC), ALIVE Study
176. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
177. Retrovirus receptors
178. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
179. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
180. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
181. Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells
182. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
183. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
184. Dual effect of interleukin 4 on HIV-1 expression: Implications for viral phenotypic switch and disease progression
185. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
186. IL-16 anti-HIV-1 therapy
187. The two membrane proximal domains of CD4 interact with the T cell receptor
188. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells
189. CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins
190. Envelope properties of human T-cell leukemia viruses
191. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles
192. Atomic structure of the ectodomain from HIV-1 gp41
193. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
194. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes
195. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness
196. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study Francisco City Cohort (SFCC)
197. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
198. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
199. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
200. Constitutive cell surface association between CD4 and CCR5
201. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule
202. Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector containing the CD4 gene
203. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7
204. Expression and function of CCR5 and CXCR4 on human Langerhans' cells and macrophages: Implications for HIV primary infection
205. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
206. The use of inhibitors to evaluate co-receptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells
207. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression
208. The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core
209. SIV infection of macaques: Modeling the progression to AIDS dementia
210. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development